INTUITIVE SURGICAL INC (ISRG) Stock Fundamental Analysis

NASDAQ:ISRG • US46120E6023

485.84 USD
+7.24 (+1.51%)
At close: Feb 13, 2026
484.505 USD
-1.33 (-0.27%)
Pre-Market: 2/17/2026, 8:00:02 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

7

ISRG gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. ISRG gets an excellent profitability rating and is at the same time showing great financial health properties. ISRG is growing strongly while it is still valued neutral. This is a good combination! This makes ISRG very considerable for growth and quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • In the past year ISRG was profitable.
  • In the past year ISRG had a positive cash flow from operations.
  • Each year in the past 5 years ISRG has been profitable.
  • Each year in the past 5 years ISRG had a positive operating cash flow.
ISRG Yearly Net Income VS EBIT VS OCF VS FCFISRG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • ISRG has a Return On Assets of 13.96%. This is amongst the best in the industry. ISRG outperforms 96.22% of its industry peers.
  • ISRG has a Return On Equity of 16.02%. This is amongst the best in the industry. ISRG outperforms 91.89% of its industry peers.
  • The Return On Invested Capital of ISRG (13.95%) is better than 94.59% of its industry peers.
  • ISRG had an Average Return On Invested Capital over the past 3 years of 12.43%. This is above the industry average of 8.75%.
  • The last Return On Invested Capital (13.95%) for ISRG is above the 3 year average (12.43%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.96%
ROE 16.02%
ROIC 13.95%
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
ISRG Yearly ROA, ROE, ROICISRG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • ISRG has a better Profit Margin (28.38%) than 97.84% of its industry peers.
  • ISRG's Profit Margin has improved in the last couple of years.
  • The Operating Margin of ISRG (29.35%) is better than 96.76% of its industry peers.
  • In the last couple of years the Operating Margin of ISRG has grown nicely.
  • ISRG has a better Gross Margin (66.00%) than 70.81% of its industry peers.
  • ISRG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 29.35%
PM (TTM) 28.38%
GM 66%
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
ISRG Yearly Profit, Operating, Gross MarginsISRG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ISRG is creating some value.
  • ISRG has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ISRG has been increased compared to 5 years ago.
  • There is no outstanding debt for ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ISRG Yearly Shares OutstandingISRG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
ISRG Yearly Total Debt VS Total AssetsISRG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • ISRG has an Altman-Z score of 41.20. This indicates that ISRG is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of ISRG (41.20) is better than 98.38% of its industry peers.
  • There is no outstanding debt for ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 41.2
ROIC/WACC1.4
WACC9.98%
ISRG Yearly LT Debt VS Equity VS FCFISRG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • A Current Ratio of 4.87 indicates that ISRG has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 4.87, ISRG is doing good in the industry, outperforming 77.84% of the companies in the same industry.
  • A Quick Ratio of 3.96 indicates that ISRG has no problem at all paying its short term obligations.
  • ISRG has a Quick ratio of 3.96. This is in the better half of the industry: ISRG outperforms 75.14% of its industry peers.
Industry RankSector Rank
Current Ratio 4.87
Quick Ratio 3.96
ISRG Yearly Current Assets VS Current LiabilitesISRG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. Growth

3.1 Past

  • ISRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.83%, which is quite impressive.
  • The Earnings Per Share has been growing by 21.42% on average over the past years. This is a very strong growth
  • The Revenue has grown by 20.51% in the past year. This is a very strong growth!
  • ISRG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.22% yearly.
EPS 1Y (TTM)21.83%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%14.48%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%18.76%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.00% on average over the next years. This is quite good.
  • Based on estimates for the next years, ISRG will show a quite strong growth in Revenue. The Revenue will grow by 12.91% on average per year.
EPS Next Y14.46%
EPS Next 2Y14.31%
EPS Next 3Y14.59%
EPS Next 5Y14%
Revenue Next Year15.92%
Revenue Next 2Y14.87%
Revenue Next 3Y14.63%
Revenue Next 5Y12.91%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ISRG Yearly Revenue VS EstimatesISRG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B
ISRG Yearly EPS VS EstimatesISRG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 54.41 indicates a quite expensive valuation of ISRG.
  • ISRG's Price/Earnings ratio is a bit cheaper when compared to the industry. ISRG is cheaper than 67.03% of the companies in the same industry.
  • ISRG is valuated expensively when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 47.53, ISRG can be considered very expensive at the moment.
  • ISRG's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ISRG is cheaper than 67.03% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. ISRG is valued rather expensively when compared to this.
Industry RankSector Rank
PE 54.41
Fwd PE 47.53
ISRG Price Earnings VS Forward Price EarningsISRG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ISRG is valued a bit cheaper than 65.41% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, ISRG is valued a bit cheaper than the industry average as 70.81% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 69.27
EV/EBITDA 45.12
ISRG Per share dataISRG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The excellent profitability rating of ISRG may justify a higher PE ratio.
  • ISRG's earnings are expected to grow with 14.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.76
PEG (5Y)2.54
EPS Next 2Y14.31%
EPS Next 3Y14.59%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ISRG!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INTUITIVE SURGICAL INC

NASDAQ:ISRG (2/13/2026, 8:18:03 PM)

Premarket: 484.505 -1.33 (-0.27%)

485.84

+7.24 (+1.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22
Earnings (Next)04-20
Inst Owners88.29%
Inst Owner Change0.01%
Ins Owners0.45%
Ins Owner Change1.75%
Market Cap172.54B
Revenue(TTM)10.06B
Net Income(TTM)2.86B
Analysts78.1
Price Target625.53 (28.75%)
Short Float %2.03%
Short Ratio3.71
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.28%
Min EPS beat(2)9.85%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)10.81%
Min EPS beat(4)3.05%
Max EPS beat(4)18.71%
EPS beat(8)8
Avg EPS beat(8)11.52%
EPS beat(12)12
Avg EPS beat(12)8.73%
EPS beat(16)14
Avg EPS beat(16)6.39%
Revenue beat(2)2
Avg Revenue beat(2)2.19%
Min Revenue beat(2)2.17%
Max Revenue beat(2)2.22%
Revenue beat(4)4
Avg Revenue beat(4)1.83%
Min Revenue beat(4)1.09%
Max Revenue beat(4)2.22%
Revenue beat(8)5
Avg Revenue beat(8)1.43%
Revenue beat(12)7
Avg Revenue beat(12)0.96%
Revenue beat(16)9
Avg Revenue beat(16)0.46%
PT rev (1m)1.44%
PT rev (3m)2.76%
EPS NQ rev (1m)0.17%
EPS NQ rev (3m)0.31%
EPS NY rev (1m)3%
EPS NY rev (3m)3.32%
Revenue NQ rev (1m)0.53%
Revenue NQ rev (3m)0.53%
Revenue NY rev (1m)1.01%
Revenue NY rev (3m)1.05%
Valuation
Industry RankSector Rank
PE 54.41
Fwd PE 47.53
P/S 17.14
P/FCF 69.27
P/OCF 56.93
P/B 9.68
P/tB 9.9
EV/EBITDA 45.12
EPS(TTM)8.93
EY1.84%
EPS(NY)10.22
Fwd EY2.1%
FCF(TTM)7.01
FCFY1.44%
OCF(TTM)8.53
OCFY1.76%
SpS28.34
BVpS50.19
TBVpS49.1
PEG (NY)3.76
PEG (5Y)2.54
Graham Number100.42
Profitability
Industry RankSector Rank
ROA 13.96%
ROE 16.02%
ROCE 16.01%
ROIC 13.95%
ROICexc 20.73%
ROICexgc 21.4%
OM 29.35%
PM (TTM) 28.38%
GM 66%
FCFM 24.75%
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
ROICexc(3y)18.4%
ROICexc(5y)18.81%
ROICexgc(3y)19.07%
ROICexgc(5y)19.65%
ROCE(3y)14.27%
ROCE(5y)14.28%
ROICexgc growth 3Y2.03%
ROICexgc growth 5Y0.92%
ROICexc growth 3Y2.86%
ROICexc growth 5Y2.05%
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
F-Score8
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 79.72%
Cap/Sales 5.36%
Interest Coverage 250
Cash Conversion 83.46%
Profit Quality 87.21%
Current Ratio 4.87
Quick Ratio 3.96
Altman-Z 41.2
F-Score8
WACC9.98%
ROIC/WACC1.4
Cap/Depr(3y)178.7%
Cap/Depr(5y)155.64%
Cap/Sales(3y)11.2%
Cap/Sales(5y)9.67%
Profit Quality(3y)61.68%
Profit Quality(5y)71.87%
High Growth Momentum
Growth
EPS 1Y (TTM)21.83%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%14.48%
EPS Next Y14.46%
EPS Next 2Y14.31%
EPS Next 3Y14.59%
EPS Next 5Y14%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%18.76%
Revenue Next Year15.92%
Revenue Next 2Y14.87%
Revenue Next 3Y14.63%
Revenue Next 5Y12.91%
EBIT growth 1Y25.34%
EBIT growth 3Y22.76%
EBIT growth 5Y22.63%
EBIT Next Year34.54%
EBIT Next 3Y22.15%
EBIT Next 5Y17.41%
FCF growth 1Y91.03%
FCF growth 3Y37.49%
FCF growth 5Y16.85%
OCF growth 1Y25.49%
OCF growth 3Y26.68%
OCF growth 5Y15.34%

INTUITIVE SURGICAL INC / ISRG FAQ

Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?

ChartMill assigns a fundamental rating of 7 / 10 to ISRG.


What is the valuation status of INTUITIVE SURGICAL INC (ISRG) stock?

ChartMill assigns a valuation rating of 4 / 10 to INTUITIVE SURGICAL INC (ISRG). This can be considered as Fairly Valued.


How profitable is INTUITIVE SURGICAL INC (ISRG) stock?

INTUITIVE SURGICAL INC (ISRG) has a profitability rating of 9 / 10.


What are the PE and PB ratios of INTUITIVE SURGICAL INC (ISRG) stock?

The Price/Earnings (PE) ratio for INTUITIVE SURGICAL INC (ISRG) is 54.41 and the Price/Book (PB) ratio is 9.68.


Can you provide the financial health for ISRG stock?

The financial health rating of INTUITIVE SURGICAL INC (ISRG) is 9 / 10.